Glenmark gets US nod to market Mupirocin skin cream

Pharmaceutical company Glenmark 's US subsidiary Glenmark Generics has received final approval from US Food and Drugs Administration for its abbreviated new drug application for Mupirocin Calcium Cream USP, 2 percent.

Mupirocin Calcium Cream is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length) caused by bacteria such as S aureus and S pyogenes, Glenmark said on Monday.

The cream had US sales of USD 56.5 million for the year-ended Sept 2012, it added, citing IMS Health data.

Glenmark now has 83 products authorized for distribution in the US and a further 46 ANDAs are pending approval with the FDA.

Glenmark shares hit a high of Rs 534.80 in morning trade on Monday and at 9:45 hrs, it was up 0.5 percent at Rs 517.35.

Also Read: Hexaware says not lost any clients; company on growth track